To confirm whether the PPARs were associated with the protective effects of ICS II against BCCAO-induced cognitive impairment, the protein expression levels of PPARα, PPARβ, and PPARγ were examined after 28 consecutive days treatment of ICS II. Here, PPARG is linked to Cognitive impairment.